Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 7 | 2020 | 682 | 1.100 |
Why?
|
Organ Transplantation | 7 | 2024 | 1177 | 1.080 |
Why?
|
Chickenpox | 2 | 2023 | 96 | 0.970 |
Why?
|
Cerebellar Neoplasms | 5 | 2020 | 590 | 0.890 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2020 | 133 | 0.640 |
Why?
|
Nutritional Requirements | 2 | 2011 | 279 | 0.620 |
Why?
|
Biliary Atresia | 1 | 2019 | 88 | 0.620 |
Why?
|
Tissue Donors | 4 | 2024 | 2389 | 0.590 |
Why?
|
Herpesvirus 8, Human | 1 | 2019 | 256 | 0.560 |
Why?
|
Cytomegalovirus Infections | 2 | 2023 | 839 | 0.550 |
Why?
|
Metagenomics | 1 | 2020 | 475 | 0.540 |
Why?
|
Body Composition | 3 | 2018 | 2461 | 0.520 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 374 | 0.510 |
Why?
|
Immunocompromised Host | 2 | 2022 | 863 | 0.500 |
Why?
|
Communicable Diseases | 2 | 2020 | 873 | 0.480 |
Why?
|
Candidiasis, Invasive | 2 | 2024 | 25 | 0.460 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2020 | 783 | 0.450 |
Why?
|
HIV Infections | 9 | 2020 | 17575 | 0.440 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.430 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2018 | 1903 | 0.420 |
Why?
|
Vaccination | 4 | 2022 | 3431 | 0.410 |
Why?
|
Body Fluid Compartments | 1 | 2011 | 50 | 0.390 |
Why?
|
Hospitals, Pediatric | 2 | 2023 | 1876 | 0.390 |
Why?
|
Vaccines | 1 | 2020 | 842 | 0.370 |
Why?
|
Intestines | 1 | 2020 | 1912 | 0.370 |
Why?
|
Child | 32 | 2024 | 80891 | 0.330 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2008 | 50 | 0.320 |
Why?
|
Adiposity | 1 | 2018 | 1895 | 0.310 |
Why?
|
Attitude | 1 | 2013 | 772 | 0.300 |
Why?
|
Heart Transplantation | 1 | 2022 | 3300 | 0.300 |
Why?
|
Health Promotion | 1 | 2020 | 2209 | 0.290 |
Why?
|
Insulin Resistance | 3 | 2020 | 3981 | 0.290 |
Why?
|
Antifungal Agents | 3 | 2024 | 759 | 0.290 |
Why?
|
Parenteral Nutrition | 1 | 2011 | 663 | 0.280 |
Why?
|
Liver Transplantation | 1 | 2019 | 2400 | 0.270 |
Why?
|
Antiviral Agents | 5 | 2024 | 3064 | 0.270 |
Why?
|
Ependymoma | 2 | 2019 | 328 | 0.250 |
Why?
|
DNA Methylation | 7 | 2020 | 4421 | 0.230 |
Why?
|
Hepatitis B Antibodies | 1 | 2024 | 156 | 0.220 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1794 | 0.220 |
Why?
|
Adolescent | 21 | 2024 | 89184 | 0.220 |
Why?
|
Dietary Carbohydrates | 1 | 2008 | 896 | 0.220 |
Why?
|
Infant | 13 | 2024 | 36510 | 0.220 |
Why?
|
Rubella | 1 | 2023 | 55 | 0.220 |
Why?
|
Health Status Indicators | 1 | 2008 | 971 | 0.220 |
Why?
|
Candidemia | 1 | 2023 | 39 | 0.210 |
Why?
|
Dietary Proteins | 1 | 2008 | 960 | 0.210 |
Why?
|
Mumps | 1 | 2023 | 71 | 0.210 |
Why?
|
Ganciclovir | 2 | 2023 | 256 | 0.200 |
Why?
|
Virus Activation | 1 | 2024 | 322 | 0.200 |
Why?
|
Family | 1 | 2013 | 3208 | 0.200 |
Why?
|
Child, Preschool | 17 | 2024 | 42650 | 0.200 |
Why?
|
Aspergillosis | 2 | 2022 | 242 | 0.200 |
Why?
|
Measles | 1 | 2023 | 181 | 0.190 |
Why?
|
Mitochondria | 2 | 2020 | 3675 | 0.190 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 159 | 0.190 |
Why?
|
Lymphopenia | 1 | 2023 | 299 | 0.180 |
Why?
|
Caregivers | 1 | 2013 | 2303 | 0.180 |
Why?
|
Mycoses | 2 | 2014 | 386 | 0.180 |
Why?
|
Hepatitis B virus | 1 | 2024 | 530 | 0.180 |
Why?
|
Energy Intake | 1 | 2008 | 2145 | 0.180 |
Why?
|
Energy Metabolism | 1 | 2011 | 2906 | 0.180 |
Why?
|
Dietary Fats | 1 | 2008 | 2003 | 0.180 |
Why?
|
Vancomycin Resistance | 1 | 2020 | 125 | 0.170 |
Why?
|
JC Virus | 1 | 2020 | 87 | 0.170 |
Why?
|
Adipose Tissue | 1 | 2011 | 3334 | 0.170 |
Why?
|
NFI Transcription Factors | 1 | 2019 | 42 | 0.170 |
Why?
|
Travel Medicine | 1 | 2020 | 83 | 0.170 |
Why?
|
Absorptiometry, Photon | 2 | 2018 | 1752 | 0.160 |
Why?
|
Cytomegalovirus | 2 | 2023 | 754 | 0.160 |
Why?
|
Cranial Irradiation | 2 | 2020 | 395 | 0.160 |
Why?
|
HTLV-I Infections | 1 | 2019 | 104 | 0.160 |
Why?
|
Brain Stem Neoplasms | 1 | 2021 | 191 | 0.160 |
Why?
|
Humans | 45 | 2024 | 768393 | 0.160 |
Why?
|
Hepatitis B | 1 | 2024 | 708 | 0.160 |
Why?
|
Histones | 2 | 2021 | 2592 | 0.150 |
Why?
|
Viral Vaccines | 1 | 2023 | 596 | 0.150 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 192 | 0.150 |
Why?
|
Neutropenia | 1 | 2023 | 893 | 0.150 |
Why?
|
Genes, myc | 1 | 2019 | 391 | 0.150 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 99 | 0.140 |
Why?
|
Vancomycin | 1 | 2020 | 505 | 0.140 |
Why?
|
Donor Selection | 1 | 2019 | 240 | 0.140 |
Why?
|
Hepacivirus | 1 | 2024 | 1342 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2013 | 5713 | 0.140 |
Why?
|
Brain Neoplasms | 4 | 2019 | 9198 | 0.140 |
Why?
|
DNA, Viral | 2 | 2024 | 2205 | 0.140 |
Why?
|
Neural Stem Cells | 2 | 2021 | 891 | 0.130 |
Why?
|
Postoperative Complications | 1 | 2019 | 15881 | 0.130 |
Why?
|
src-Family Kinases | 1 | 2018 | 539 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 986 | 0.130 |
Why?
|
Male | 23 | 2024 | 364902 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 620 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2020 | 1837 | 0.120 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 2046 | 0.120 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 621 | 0.120 |
Why?
|
Schools | 2 | 2022 | 1496 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4646 | 0.120 |
Why?
|
Genetic Techniques | 1 | 2017 | 428 | 0.120 |
Why?
|
Steroids | 1 | 2019 | 937 | 0.110 |
Why?
|
Fungi | 2 | 2014 | 345 | 0.110 |
Why?
|
Hepatitis C | 1 | 2024 | 1593 | 0.110 |
Why?
|
Female | 23 | 2024 | 397089 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1627 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1343 | 0.110 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1748 | 0.110 |
Why?
|
Heart Diseases | 2 | 2022 | 2819 | 0.110 |
Why?
|
Electron Transport Complex IV | 1 | 2013 | 192 | 0.110 |
Why?
|
Electron Transport Complex I | 1 | 2013 | 153 | 0.100 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7453 | 0.100 |
Why?
|
Glioblastoma | 2 | 2017 | 3526 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1248 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6541 | 0.090 |
Why?
|
Paclitaxel | 1 | 2019 | 1736 | 0.090 |
Why?
|
Disease Progression | 3 | 2019 | 13646 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1855 | 0.090 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2018 | 1360 | 0.090 |
Why?
|
Oxidative Phosphorylation | 1 | 2013 | 501 | 0.090 |
Why?
|
Diet | 2 | 2008 | 8090 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9510 | 0.090 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2017 | 954 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14784 | 0.090 |
Why?
|
Cohort Studies | 8 | 2024 | 41795 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2023 | 81801 | 0.080 |
Why?
|
Young Adult | 7 | 2020 | 60049 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1889 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2911 | 0.080 |
Why?
|
Prospective Studies | 7 | 2020 | 54920 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 871 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3666 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2533 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2296 | 0.070 |
Why?
|
RNA | 1 | 2017 | 2726 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9636 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1539 | 0.070 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11516 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2909 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2008 | 793 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9371 | 0.070 |
Why?
|
Incidence | 3 | 2020 | 21544 | 0.060 |
Why?
|
Glioma | 1 | 2021 | 3526 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2013 | 2740 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2008 | 15649 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14737 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5800 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10654 | 0.060 |
Why?
|
Hepatitis B Core Antigens | 1 | 2024 | 90 | 0.060 |
Why?
|
Chickenpox Vaccine | 1 | 2023 | 40 | 0.060 |
Why?
|
Adult | 9 | 2019 | 223640 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2023 | 70 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5891 | 0.050 |
Why?
|
Primary Health Care | 1 | 2020 | 4748 | 0.050 |
Why?
|
Genomics | 1 | 2019 | 5916 | 0.050 |
Why?
|
Liver | 1 | 2019 | 7574 | 0.050 |
Why?
|
Nutritional Status | 2 | 2008 | 1627 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Asthma | 1 | 2022 | 6280 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Body Surface Area | 1 | 2023 | 206 | 0.050 |
Why?
|
Vaccines, Attenuated | 1 | 2023 | 314 | 0.050 |
Why?
|
HIV Seropositivity | 1 | 2008 | 962 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9614 | 0.050 |
Why?
|
Qualitative Research | 1 | 2013 | 3131 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36849 | 0.050 |
Why?
|
Aspergillus | 1 | 2022 | 95 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7463 | 0.050 |
Why?
|
Cerebellum | 2 | 2019 | 1514 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4291 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 13052 | 0.040 |
Why?
|
HIV | 1 | 2008 | 1596 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24318 | 0.040 |
Why?
|
Advisory Committees | 1 | 2024 | 797 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12166 | 0.040 |
Why?
|
Risk Factors | 7 | 2023 | 74962 | 0.040 |
Why?
|
Viral Load | 1 | 2008 | 3398 | 0.040 |
Why?
|
Triazoles | 1 | 2024 | 904 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2202 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6430 | 0.040 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2019 | 143 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2019 | 669 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2011 | 12456 | 0.040 |
Why?
|
Spain | 1 | 2018 | 492 | 0.040 |
Why?
|
Prognosis | 3 | 2017 | 30022 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11854 | 0.040 |
Why?
|
Hospitalization | 3 | 2023 | 10844 | 0.030 |
Why?
|
Puerto Rico | 1 | 2018 | 380 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1839 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4411 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1159 | 0.030 |
Why?
|
RNA, Viral | 1 | 2024 | 2866 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30228 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2632 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22296 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 753 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5375 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2019 | 770 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1183 | 0.030 |
Why?
|
United States | 5 | 2022 | 73150 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1265 | 0.030 |
Why?
|
Travel | 1 | 2020 | 800 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1526 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1193 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1722 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2139 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26375 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2018 | 1794 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8634 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2791 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4629 | 0.030 |
Why?
|
Mice | 4 | 2021 | 82017 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17135 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2008 | 4571 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22385 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18471 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1614 | 0.020 |
Why?
|
HIV-1 | 1 | 2008 | 6963 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8753 | 0.020 |
Why?
|
Animals | 5 | 2022 | 169337 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 2018 | 780 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2019 | 2448 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2574 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2846 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3553 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1974 | 0.020 |
Why?
|
Logistic Models | 1 | 2023 | 13323 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4120 | 0.020 |
Why?
|
Proteome | 1 | 2018 | 1881 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2058 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8326 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10588 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8902 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7145 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26411 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3960 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15597 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 40272 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9261 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3231 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 59686 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9562 | 0.020 |
Why?
|
Signal Transduction | 2 | 2019 | 23631 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5801 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3543 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 223491 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3858 | 0.010 |
Why?
|
Proteomics | 1 | 2018 | 3906 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5451 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3827 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2024 | 65379 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15455 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15872 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9513 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
Aged | 2 | 2018 | 171562 | 0.010 |
Why?
|
Exercise | 1 | 2008 | 5946 | 0.010 |
Why?
|
Concepts
(260)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_